+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Growth Hormone, Insulin-Like Growth Factor-1, Insulin Resistance, and Leukocyte Telomere Length as Determinants of Arterial Aging in Subjects Free of Cardiovascular Diseases



Growth Hormone, Insulin-Like Growth Factor-1, Insulin Resistance, and Leukocyte Telomere Length as Determinants of Arterial Aging in Subjects Free of Cardiovascular Diseases



Frontiers in Genetics 8: 198



Background: Increased arterial stiffness (AS), intima-media thickness (IMT), and the presence of atherosclerotic plaques (PP) have been considered as important aspects of vascular aging. It is well documented that the cardiovascular system is an important target organ for growth hormone (GH) and insulin-like growth factor (IGF)-1 in humans, and GH /IGF-1 deficiency significantly increases the risk for cardiovascular diseases (CVD). The telomere length of peripheral blood leukocytes (LTL) is a biomarker of cellular senescence and that has been proposed as an independent predictor of (CVD). The aim of this study is to determine the role of GH/IGF-1, LTL and their interaction cardiovascular risk factors (CVRF) in the vascular aging. Methods: The study group included 303 ambulatory participants free of known CVD (104 males and 199 females) with a mean age of 51.8 ± 13.3 years. All subjects had one or more CVRF [age, smoking, arterial hypertension, obesity, dyslipidemia, fasting hyperglycemia, insulin resistance-HOMA (homeostatic model assessment) >2.5, or high glycated hemoglobin]. The study sample was divided into the two groups according to age as "younger" (m ≤ 45 years, f ≤ 55 years) and "older" (m > 45 years, f > 55 years). IMT and PP were determined by ultrasonography, AS was determined by measuring the carotid-femoral pulse wave velocity (c-f PWV) using the SphygmoCor system (AtCor Medical). LTL was determined by PCR. Serum IGF-1 and GH concentrations we measured by immunochemiluminescence analysis. Results: Multiple linear regression analysis with adjustment for CVRF indicated that HOMA, GH, IGF-1, and LTL had an independent relationship with all the arterial wall parameters investigated in the younger group. In the model with c-f PWV as a dependent variable, p < 0.001 for HOMA, p = 0.03 for GH, and p = 0.004 for LTL. In the model with IMT as a dependent variable, p = 0.0001 for HOMA, p = 0.044 for GH, and p = 0.004 for IGF-1. In the model with the number of plaques as a dependent variable, p = 0.0001 for HOMA, and p = 0.045 for IGF-1. In the older group, there were no independent significant associations between GH/IGF-1, LTL, HOMA, and arterial wall characteristics. Conclusions: GH/IGF-1, IR, HOMA, and LTL were the important parameters of arterial aging in younger healthy participants.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 065181991

Download citation: RISBibTeXText

PMID: 29375617

DOI: 10.3389/fgene.2017.00198


Related references

Association of Insulin Resistance, Arterial Stiffness and Telomere Length in Adults Free of Cardiovascular Diseases. Plos one 10(8): E0136676, 2015

Possible roles of insulin glucagon growth hormone and free fatty acids in the pathogenesis of insulin resistance of subjects with chronic liver diseases. Acta Diabetologica Latina 21(3): 241-250, 1984

Insulin-like growth factors and leukocyte telomere length: the cardiovascular health study. Journals of Gerontology. Series A Biological Sciences and Medical Sciences 64(11): 1103-1106, 2009

Responses of total and free insulin-like growth factor-I and insulin-like growth factor binding protein-3 after resistance exercise and training in elderly subjects. Acta Physiologica Scandinavica 165(1): 51-56, 1999

The relationship of insulin-like growth factor-I, insulin-like growth factor binding protein-3, insulin, and growth hormone in cord blood with the birth weight and length. Hormone Research 48(Suppl. 2): 29, 1997

Insulin-like growth factor-I and insulin-like growth factor binding protein-3 cotreatment versus insulin-like growth factor-I alone in two brothers with growth hormone insensitivity syndrome: effects on insulin sensitivity, body composition and linear growth. Hormone Research in Paediatrics 76(5): 355-366, 2011

Growth hormone-insulin-like growth factor-I axis in adult insulin-dependent diabetic patients: Evidence for central hypersensitivity to growth hormone - releasing hormone and peripheral resistance to growth hormone. Hormone & Metabolic Research 30(12): 737-742, 1998

Growth hormone-insulin-like growth factor-I axis in adult insulin-dependent diabetic patients: evidence for central hypersensitivity to growth hormone-releasing hormone and peripheral resistance to growth hormone. Hormone and Metabolic Research 30(12): 737-742, 1998

Adult growth hormone deficiency treatment with a combination of growth hormone and insulin-like growth factor-1 resulting in elevated sustainable insulin-like growth factor-1 and insulin-like growth factor binding protein 3 plasma levels: a case report. Journal of Medical Case Reports 4: 305, 2010

Effect of growth hormone releasing factor 1 29 amide grf infusion and somatostatin immunization on growth hormone gh thyroxine t 4 insulin insulin like growth factor i igf i glucose and free fatty acid ffa of growing pigs. Journal of Dairy Science 72(Suppl. 1): 196, 1989

Serum insulin-like growth factor-I concentration is associated with leukocyte telomere length in a population-based cohort of elderly men. Journal of Clinical Endocrinology and Metabolism 94(12): 5078-5084, 2009

Determinants of serum insulin-like growth factor I in growth hormone deficient adults as compared to healthy subjects. Clinical Endocrinology. 48(4): 479-486, Il, 1998

Growth hormone, insulin-like growth factor-1 and the aging cardiovascular system. Cardiovascular Research 54(1): 25-35, 2002

Insulin-like growth factor I and insulin-like growth factor binding protein 3 as determinants of blood hemoglobin concentration in healthy subjects. Pediatric Research 36(6): 745-748, 1994

Changes in serum concentrations of growth hormone, insulin, insulin-like growth factor and insulin-like growth factor-binding proteins 1 and 3 and urinary growth hormone excretion during menstrual cycle. Human Reproduction 12(10): 2123-2128, 1997